Skip to main content
Caplight Logo









Remidose Aerosols Inc.

Remidose Aerosols Inc.

Private
StratfordHealthcare & Life Scienceshttps://www.remidose.com/

Last Round

Accelerator

Aug 27, 2021

Total Funding Raised

$60,000

Company Overview

Remidose Aerosols Inc. is a cannabis company that manufactures medical devices and cannabis-based products, including metered-dose inhalers and topical formulations.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share

AI Layer

Non-AI

Keywords

metered-dose inhalercannabis delivery deviceprecision dosingcannabis oilmedical cannabisvape techcannabis techdrug delivery technologyoral spraycannabis licensingIP licensingtopical formulationcannabis processorroyalty model

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Remidose Aerosols Inc. Comparables

Compare Remidose Aerosols Inc. with similar companies based on industry and business-model similarity.

Remidose Aerosols Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Syqe Medical
78%
Roxx Labs
75%
Medipharm Labs Corp
72%

Remidose Aerosols Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorAug 27, 2021
GrantJul 26, 2021
GrantDec 18, 2020

Remidose Aerosols Inc. Investors

Notable investors and investment history

Remidose Aerosols Inc. investors
InvestorRounds
Atlantic Canada Opportunities AgencyGrant
Emergence IncubatorAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2021

    $40K grant received from Atlantic Canada Opportunities Agency.

Remidose Aerosols Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Remidose Aerosols Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Remidose Aerosols Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersStratford
Year Founded2020
Last FundingAug 27, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?